MedTrace Logo

The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer

NCT01942759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2014-06-10

No results posted yet for this study

Summary

The purpose of this study is to determine findings of positron emission tomography and diffusion weighted magnetic resonance in primary lesion and axillary metastasis of breast cancer and compare of two imaging modality in these patients.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • Bagcilar Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • AYNUR OZEN, MD · Bagcilar Training & Research Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01942759 on ClinicalTrials.gov